Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy H J Florin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|March 12, 2004
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitionersTimothy H J Florin
Journal of Gastroenterology and Hepatology|May 20, 2003
Resistance to glucocorticosteroid therapy in inflammatory bowel diseaseTimothy H J Florin
Journal of Crohn'S & Colitis|December 3, 2010
A role for B₁₂ in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B₁₂ therapyMarianne Mortimore, Timothy H J Florin
Therapeutic Drug Monitoring|September 22, 2005
Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotidesJohn A Duley, Timothy H J Florin
The Medical Journal of Australia|August 16, 2005
Tumour necrosis factor inhibitorsPeter T Nash, Timothy H J Florin
Journal of Gastroenterology and Hepatology|October 16, 2008
Azathioprine: when less is moreJohn A Duley, Timothy H J Florin
The Medical Journal of Australia|March 20, 2009
Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's diseaseDaniel C Burger, Timothy H J Florin
Plos One|December 18, 2008
Mucin dynamics in intestinal bacterial infectionSara K Lindén, Timothy H J Florin, Michael A McGuckin
Gut|July 16, 2013
Spontaneous oesophageal perforation: an unreported complication of lymphocytic oesophagitisPeter J Hendy, David S Wong, Timothy H J Florin
Journal of Gastroenterology and Hepatology|September 15, 2011
Mucins in inflammatory bowel diseases and colorectal cancerYong H Sheng, Sumaira Z Hasnain, Timothy H J Florin, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|March 12, 2004
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitionersTimothy H J Florin
Journal of Gastroenterology and Hepatology|May 20, 2003
Resistance to glucocorticosteroid therapy in inflammatory bowel diseaseTimothy H J Florin
Journal of Crohn'S & Colitis|December 3, 2010
A role for B₁₂ in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B₁₂ therapyMarianne Mortimore, Timothy H J Florin
Therapeutic Drug Monitoring|September 22, 2005
Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotidesJohn A Duley, Timothy H J Florin
The Medical Journal of Australia|August 16, 2005
Tumour necrosis factor inhibitorsPeter T Nash, Timothy H J Florin
Journal of Gastroenterology and Hepatology|October 16, 2008
Azathioprine: when less is moreJohn A Duley, Timothy H J Florin
The Medical Journal of Australia|March 20, 2009
Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's diseaseDaniel C Burger, Timothy H J Florin
Plos One|December 18, 2008
Mucin dynamics in intestinal bacterial infectionSara K Lindén, Timothy H J Florin, Michael A McGuckin
Gut|July 16, 2013
Spontaneous oesophageal perforation: an unreported complication of lymphocytic oesophagitisPeter J Hendy, David S Wong, Timothy H J Florin
Journal of Gastroenterology and Hepatology|September 15, 2011
Mucins in inflammatory bowel diseases and colorectal cancerYong H Sheng, Sumaira Z Hasnain, Timothy H J Florin, et al.
Pageof 3